FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-115683.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-115683v1
23/4/1161    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pacheco-López, G.
Right arrow Articles by Schedlowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pacheco-López, G.
Right arrow Articles by Schedlowski, M.
(The FASEB Journal. 2009;23:1161-1167.)
© 2009 FASEB

Calcineurin inhibition in splenocytes induced by pavlovian conditioning

Gustavo Pacheco-López*,1,2, Carsten Riether*,1, Raphael Doenlen*, Harald Engler*,{dagger}, Maj-Britt Niemi*, Andrea Engler*, Annemieke Kavelaars{ddagger}, Cobi J. Heijnen{ddagger} and Manfred Schedlowski{dagger}

* Department of Psychology and Behavioral Immunobiology, Institute for Behavioral Sciences, ETH Zurich, Zurich, Switzerland;

{dagger} Division of Medical Psychology and Behavioral Immunobiology, Medical Faculty, University of Duisburg-Essen, Essen, Germany; and

{ddagger} Laboratory of Psychoneuroimmunology, University Medical Center Utrecht, Utrecht, The Netherlands

2Correspondence: Institute for Behavioral Sciences, Psychology and Behavioral Immunobiology, TUR B21.1, Turnerstrasse 1, 8092 Zurich, Switzerland. E-mail: pacheco{at}ifv.gess.ethz.ch

Pavlovian conditioning is one of the major neurobiological mechanisms of placebo effects, potentially influencing the course of specific diseases and the response to a pharmacological therapy, such as immunosuppression. In our study with behaviorally conditioned rats, a relevant taste (0.2% saccharin) preceded the application of the immunosuppressive drug cyclosporin A (CsA), a specific calcineurin (CaN) inhibitor. Our results demonstrate that through pavlovian conditioning the particular pharmacological properties of CsA can be transferred to a neutral taste, i.e., CaN activity was inhibited in splenocytes from conditioned rats after reexposure to the gustatory stimulus. Concomitant immune consequences were observed on ex vivo mitogenic challenge (anti-CD3). Particularly, Th1-cytokine, but not Th2-cytokine, production and cell proliferation were impeded. Appropriate pharmacological and behavioral controls certify that all these changes in T-lymphocyte reactivity are attributable to mere taste reexposure. Furthermore, the underlying sympathetic-lymphocyte interaction was revealed modeling the conditioned response in vitro. CaN activity in CD4+ T lymphocytes is reduced by β-adrenergic stimulation (terbutaline), with these effects antagonized by the β-adrenoreceptor antagonist nadolol. In summary, CaN was identified as the intracellular target for inducing conditioned immunosuppression by CsA, contributing to our understanding of the intracellular mechanisms behind "learned placebo effects."—Pacheco-López, G., Riether, C., Doenlen, R., Engler, H., Niemi, M.-B., Engler, A., Kavelaars, A., Heijnen, C. J., Schedlowski, M. Calcineurin inhibition in splenocytes induced by pavlovian conditioning.


Key Words: cyclosporin A • immunosuppression • associative learning • placebo • taste







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.